Utuc clinical trials

Explore recruiting utuc clinical trials.

Recruiting utuc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Utuc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neo-adjuvant versus Adjuvant chemotherapy in Upper Tract Urothelial Carcinoma: A feasibility phase II randomized clinical trial (“URANUS”)

Norway, Spain, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Protocol Title: A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-grade Upper Tract Urothelial Cancer (LG-UTUC)

Hungary, Poland, Romania, Spain, Bulgaria, Latvia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects with Low-Grade Upper Tract Urothelial Carcinoma (LG-UTUC)

Spain, France, Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase III Randomized, Open-Label, Multi-Center, GlobalStudy of Durvalumab and Bacillus Calmette-Guerin (BCG)Administered as Combination Therapy Versus BCG Alone inHigh-Risk, BCG Naïve Non Muscle Invasive Bladder Cancer Patients (POTOMAC)

Germany, Austria, France, Belgium, Netherlands, Poland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low-Grade Upper Tract Urothelial Cancer

Germany, Austria, Spain, Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2A/B, Multi-center, Open-Label Study Evaluating the Efficacy and Safety of Dabogratinib (TYRA-300) in Participants with Low Grade Upper Tract Urothelial Carcinoma (SURF303)

Bulgaria, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Utuc trials by city

Utuc in Toronto Utuc in Vancouver Utuc in Montreal Utuc in Calgary Utuc in Edmonton Utuc in Ottawa Utuc in Winnipeg Utuc in Quebec City Utuc in Hamilton Utuc in Kitchener Utuc in London Utuc in Halifax Utuc in New York Utuc in Los Angeles Utuc in Chicago Utuc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease